Table 4. Comparison of lean vs. obese women in each individual phenotype (p-values only).
Variable | Lean A vs. Obese A | Lean B vs. Obese B | Lean C vs. Obese C | Lean D vs. Obese D |
---|---|---|---|---|
WHR | 0.002 | 0.576 | 0.118 | <0.0001 |
FBS (mg/dl) | 0.046 | 0.305 | 0.734 | 0.001 |
2h glucose (mg/dl) | 0.176 | 0.473 | 0.084 | 0.001 |
Insulin (μIU/ml) | 0.001 | 0.501 | 0.303 | <0.0001 |
HOMA-IR | <0.0001 | 0.703 | 0.283 | <0.0001 |
QUICKI | 0.011 | 0.728 | 0.476 | <0.0001 |
FSH (mIU/ml) | 0.427 | 0.265 | 0.955 | 0.364 |
LH (mIU/ml) | 0.029 | 0.663 | 0.496 | 0.021 |
LH:FSH | 0.013 | 0.240 | 0.489 | 0.073 |
TT (ng/dl) | 0.087 | 0.446 | 0.346 | 0.064 |
SHBG (nmol/l) | 0.007 | 0.154 | 0.154 | 0.010 |
Free-T (pmol/l) | 0.959 | 0.629 | 0.925 | 0.416 |
Bio-T (nmol/l) | 0.840 | 0.618 | 0.935 | 0.676 |
FAI | 0.230 | 0.126 | 0.912 | 0.121 |
Total Cholesterol (mg/dl) | 0.105 | 0.454 | 0.988 | 0.055 |
HDL-C (mg/dl) | 0.002 | <0.0001 | 0.269 | <0.0001 |
TG (mg/dl) | 0.005 | 0.538 | 0.765 | <0.0001 |
LDL-C (mg/dl) | 0.007 | 0.798 | 0.580 | 0.010 |
LAP | <0.0001 | 0.024 | 0.004 | <0.0001 |
VAI | 0.001 | 0.004 | 0.856 | <0.0001 |
ApoA1 (mg/dl) | 0.727 | 0.214 | 0.639 | 0.011 |
ApoB (mg/dl) | 0.184 | 0.188 | 0.776 | 0.972 |
ApoB:ApoA1 | 0.252 | 0.826 | 0.607 | 0.032 |
Note: Significant differences (P<0.05) are indicated in bold.
ApoA-1 = apolipoprotein A-1, ApoB = apolipoprotein B, Bio-T = bioavailable testosterone, FAI = free androgen index, FBS = fasting glucose, Free-T = free testosterone, HDL-C = high density lipoprotein cholesterol, HOMA-IR = homeostasis model assessment for insulin resistance, LAP = lipid accumulation product, LDL-C = low density lipoprotein, QUICKI = quantitative insulin sensitivity check index, SHBG = sex hormone binding globulin, TG = triglycerides, TT = total testosterone, VAI = visceral adiposity index, WHR = waist to hip ratio.